Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

192 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Vitamin D in patients with low tumor-burden indolent non-Hodgkin lymphoma treated with rituximab therapy (ILyAD): a randomized, phase 3 clinical trial.
Friedberg JW, Brady MT, Strawderman M, Kahl BS, Lossos IS, Cohen JB, Reagan PM, Casulo C, Averill BL, Baran A, Sutamtewagul G, Barr PM, Leonard JP, Ashton JM, Strang JG, Vega F, Peterson DR, Nastoupil LJ. Friedberg JW, et al. Among authors: nastoupil lj. EClinicalMedicine. 2024 Nov 27;78:102959. doi: 10.1016/j.eclinm.2024.102959. eCollection 2024 Dec. EClinicalMedicine. 2024. PMID: 39677358 Free PMC article.
Lisocabtagene Maraleucel for Relapsed/Refractory Large B-Cell Lymphoma: A Cell Therapy Consortium Real-World Analysis.
Riedell PA, Grady CB, Nastoupil LJ, Luna De Abia A, Ahmed N, Maziarz RT, Hu M, Brower J, Hwang WT, Schuster SJ, Chen AI, Oluwole OO, Bachanova V, McGuirk JP, Perales MA, Bishop MR, Porter DL. Riedell PA, et al. Among authors: nastoupil lj. Blood Adv. 2024 Dec 10:bloodadvances.2024014164. doi: 10.1182/bloodadvances.2024014164. Online ahead of print. Blood Adv. 2024. PMID: 39657136
Treatment Patterns and Outcomes in Follicular Lymphoma with POD24: An Analysis from The LEO Consortium.
Day JR, Larson MC, Durani U, Koff JL, Wang Y, Habermann TM, Lossos IS, Nastoupil LJ, Strouse CS, Chihara D, Martin P, Leonard JP, Cohen JB, Kahl BS, Ruan J, Burack R, Friedberg JW, Cerhan JR, Flowers CR, Link BL, Maurer MJ, Casulo C. Day JR, et al. Among authors: nastoupil lj. Blood Adv. 2024 Nov 27:bloodadvances.2024014053. doi: 10.1182/bloodadvances.2024014053. Online ahead of print. Blood Adv. 2024. PMID: 39602301
Impact of prior CAR-T cell therapy on mosunetuzumab efficacy in patients with relapsed or refractory B-cell lymphomas.
Chong EA, Penuel E, Napier EB, Lundberg RK, Budde LE, Shadman M, Matasar MJ, Bartlett NL, Flinn IW, Bosch F, Fay K, Goy A, Kumar A, Nastoupil LJ, Wei MC, Wu M, Yin S, Fraietta JA, Chong ER, Schuster SJ. Chong EA, et al. Among authors: nastoupil lj. Blood Adv. 2024 Nov 21:bloodadvances.2024013640. doi: 10.1182/bloodadvances.2024013640. Online ahead of print. Blood Adv. 2024. PMID: 39571171
Early-Stage Extranodal NK/T-Cell Lymphoma, Nasal Type: A Role for Elective Nodal Irradiation?
Fang P, Noticewala SS, Wu SY, Gunther JR, Ludmir EB, Medeiros LJ, Strati P, Nair R, Nze C, Nastoupil LJ, Ahmed S, Castillo LM, Fayad L, Westin J, Neelapu S, Flowers C, Huen A, Iyer SP, Dabaja B, Pinnix CC. Fang P, et al. Among authors: nastoupil lj. Adv Radiat Oncol. 2024 Oct 9;9(12):101650. doi: 10.1016/j.adro.2024.101650. eCollection 2024 Dec. Adv Radiat Oncol. 2024. PMID: 39553398 Free PMC article.
Loncastuximab in high-risk and heavily pretreated relapsed / refractory diffuse large B-cell lymphoma: a real-world analysis from 21 US centers.
Zelikson V, Gurumurthi A, Sawalha Y, Annunzio K, Saha A, Dong N, Qualls D, Amoozgar B, Kahl B, Baird J, Challa P, Huntington SF, Santos J, Bair S, Narkhede M, Li S, Frosch Z, Ho C, Smith SD, Winter A, Landsburg D, Furqan F, Hamadani M, Baird K, Romancik J, Alharthy H, Law J, Bojanini L, Advani R, Hu B, Johnson PC, Grover NS, Merril M, Crombie JL, Shafagati N, Sterling C, Nastoupil LJ, Epperla N, Ayers EC. Zelikson V, et al. Among authors: nastoupil lj. Haematologica. 2024 Nov 14:0. doi: 10.3324/haematol.2024.285977. Online ahead of print. Haematologica. 2024. PMID: 39540227 Free article.
Ultra-Low-Dose Radiation for Extranodal Marginal Zone Lymphoma of the Lung.
Wu SY, Fang PQ, Fetooh A, Manzar GS, Corrigan KL, Schrank BR, Nasr L, Chihara D, Castillo LEM, Nair R, Steiner RE, Jain P, Neelapu SS, Strati P, Nastoupil LJ, Dabaja BS, Pinnix CC, Gunther JR. Wu SY, et al. Among authors: nastoupil lj. Adv Radiat Oncol. 2024 Sep 27;9(12):101648. doi: 10.1016/j.adro.2024.101648. eCollection 2024 Dec. Adv Radiat Oncol. 2024. PMID: 39524525 Free PMC article.
Long-term 3-year follow-up of mosunetuzumab in relapsed or refractory follicular lymphoma after ≥2 prior therapies.
Sehn LH, Bartlett NL, Matasar MJ, Schuster SJ, Assouline SE, Giri P, Kuruvilla J, Shadman M, Cheah CY, Dietrich S, Fay K, Ku M, Nastoupil LJ, Wei MC, Yin S, To I, Kaufman D, Kwan A, Penuel E, Bolen CR, Budde LE. Sehn LH, et al. Among authors: nastoupil lj. Blood. 2024 Oct 24:blood.2024025454. doi: 10.1182/blood.2024025454. Online ahead of print. Blood. 2024. PMID: 39447094
Antibiotic-induced loss of gut microbiome metabolic output correlates with clinical responses to CAR T-cell therapy.
Prasad R, Rehman A, Rehman L, Darbaniyan F, Blumenberg V, Schubert ML, Mor U, Zamir E, Schmidt S, Hayase T, Chia-Chi C, McDaniel LK, Flores I, Strati P, Nair R, Chihara D, Fayad LE, Ahmed S, Iyer SP, Wang ML, Jain P, Nastoupil LJ, Westin JR, Arora R, Turner JG, Khawaja F, Wu R, Dennison JB, Menges M, Hidalgo-Vargas M, Reid KM, Davila ML, Dreger P, Korell F, Schmitt A, Tanner MR, Champlin RE, Flowers CR, Shpall EJ, Hanash S, Neelapu SS, Schmitt M, Subklewe M, Fahrmann J, Stein-Thoeringer C, Elinav E, Jain MD, Hayase E, Jenq RR, Saini NY. Prasad R, et al. Among authors: nastoupil lj. Blood. 2024 Oct 23:blood.2024025366. doi: 10.1182/blood.2024025366. Online ahead of print. Blood. 2024. PMID: 39441941
Outcomes and toxicities in patients with diffuse-large B cell lymphoma involving the gastrointestinal tract and digestive organs.
Manzar GS, Cha EE, Corrigan KL, Yoder AK, Schrank BR, Nasr LF, Chihara D, Castillo LM, Nair R, Jain P, Neelapu SS, Rodriguez MA, Strati P, Nastoupil LJ, Gunther JR, Dabaja BS, Pinnix CC, Wu SY, Fang PQ. Manzar GS, et al. Among authors: nastoupil lj. Front Oncol. 2024 Sep 11;14:1447020. doi: 10.3389/fonc.2024.1447020. eCollection 2024. Front Oncol. 2024. PMID: 39324011 Free PMC article.
192 results